Gujarat Terce Laboratories Ltd

GUJTERC Share Price

BSE

₹38.503.14% (-1.25)

Health Care

Pharmaceuticals

Dheeraj Kumar Lohia Portfolio

Smallcap

With a market cap of ₹30 cr, stock is ranked 4,112

High Risk

Stock is 5.37x as volatile as Nifty

GUJTERC Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Avg

The stock has a moderate number of red flags

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Dheeraj Kumar Lohia Portfolio

Smallcap

With a market cap of ₹30 cr, stock is ranked 4,112

High Risk

Stock is 5.37x as volatile as Nifty

GUJTERC Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
-23.51	4.68	—

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
36.59	5.77	0.58%

GUJTERC Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GUJTERC Company Profile

Gujarat Terce Laboratories is engaged in manufacturing of tablets, capsules, and syrup and injection pertaining to the product group pharmaceuticals.

GUJTERC Similar Stocks (Peers)

Compare with peers Compare with peers

GUJTERC Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

39.50

1Y Return

11.49%

Buy Reco %

94.29

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

76.46

1Y Return

41.15%

Buy Reco %

81.48

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

19.20

1Y Return

14.36%

Buy Reco %

50.00

Lupin Ltd

LUPIN

PE Ratio

32.64

1Y Return

16.12%

Buy Reco %

72.22

Cipla Ltd

CIPLA

PE Ratio

20.24

1Y Return

9.62%

Buy Reco %

54.84

Compare with Peers

GUJTERC Forecast

GUJTERC Forecasts

GUJTERC

Income

Balance Sheet

Cash Flow

Financial Year		FY 2017		FY 2018		FY 2019		FY 2020		FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	TTM
Total Revenue	25.73	29.42	31.35	37.83	25.98	40.44	47.13	48.29	50.51	48.76
Raw Materials	9.37	11.03	11.84	14.28	10.25	17.88	17.70	16.65	19.29	44.34
Power & Fuel Cost	0.05	0.06	0.08	0.10	0.10	0.16	0.11	0.17	0.15
Employee Cost	10.64	11.93	12.82	14.81	12.63	15.49	14.38	15.11	15.37
Selling & Administrative Expenses	3.57	3.82	3.85	6.02	3.93	5.97	14.57	13.44	11.26
Operating & Other expenses	1.58	1.85	1.96	1.66	1.03	-0.48	2.18	1.34	0.24
EBITDA	0.52	0.73	0.80	0.96	-1.96	1.42	-1.81	1.58	4.20	4.42
Depreciation/Amortization	0.19	0.19	0.21	0.24	0.18	0.28	0.36	0.37	0.38	0.40
PBIT	0.33	0.54	0.59	0.72	-2.14	1.14	-2.17	1.21	3.82	4.02
Interest & Other Items	0.31	0.23	0.25	0.29	0.39	0.40	0.72	0.68	0.42	0.23
PBT	0.02	0.31	0.34	0.43	-2.53	0.74	-2.89	0.53	3.40	3.79
Taxes & Other Items	0.03	0.05	-0.09	0.16	-0.01	-0.13	-1.22	0.30	4.37	5.08
Net Income	-0.01	0.26	0.43	0.27	-2.52	0.87	-1.67	0.23	-0.97	-1.29
EPS	-0.01	0.35	0.58	0.36	-3.40	1.17	-2.25	0.31	-1.31	-1.74
DPS	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout ratio	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

GUJTERC Income Statement

Quarter		sep 2023		dec 2023		mar 2024		jun 2024		sep 2024	dec 2024	mar 2025	jun 2025	sep 2025	dec 2025
Total Revenue	12.11	13.10	12.29	11.96	13.38	12.75	12.41	10.95	12.98	12.42
Operating & Other expenses	11.49	12.17	11.20	11.81	11.64	11.59	11.27	10.87	11.04	11.16
EBITDA	0.62	0.93	1.09	0.15	1.74	1.16	1.14	0.08	1.94	1.26
Depreciation/Amortization	0.09	0.09	0.09	0.09	0.09	0.10	0.10	0.10	0.10	0.10
PBIT	0.53	0.84	1.00	0.06	1.65	1.06	1.04	-0.02	1.84	1.16
Interest & Other Items	0.20	0.16	0.15	0.13	0.13	0.08	0.07	0.05	0.07	0.04
PBT	0.33	0.68	0.85	-0.07	1.52	0.98	0.97	-0.07	1.77	1.12
Taxes & Other Items	0.00	0.00	0.30	0.01	0.03	-0.03	4.36	-0.03	0.38	0.37
Net Income	0.33	0.68	0.55	-0.08	1.49	1.01	-3.39	-0.04	1.39	0.75
EPS	0.45	0.91	0.73	-0.10	2.00	1.36	-4.57	-0.06	1.89	0.95

Financial Year		FY 2016		FY 2017		FY 2018		FY 2019		FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Cash from Operating Activities	0.16	0.24	4.58	-0.61	-1.59	-0.16	-0.44	0.03	2.60	3.06
Cash from Investing Activities	-0.13	0.18	1.11	-0.13	-0.27	-0.42	-0.87	0.62	-0.46	0.46
Cash from Financing Activities	-1.43	-0.36	-5.39	0.20	1.72	1.83	1.53	-0.12	-4.08	-2.83
Net Change in Cash	-1.40	+0.06	+0.30	-0.54	-0.14	+1.25	+0.22	+0.53	-1.94	+0.69
Changes in Working Capital	+0.00	+0.14	+4.20	-1.18	-2.28	+1.78	-1.78	+1.90	+1.29	-0.87
Capital Expenditures	0.06	0.01	0.28	0.40	0.48	0.50	2.11	0.06	0.07	0.00
Free Cash Flow	0.10	0.23	4.30	-1.01	-2.07	-0.66	-2.55	-0.03	2.53	3.06

GUJTERC Company Updates

FY 2025FY 2025

Annual report

PDF

FY 2024FY 2024

Annual report

PDF

Investor Presentation

Feb 5PDF

FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 13PDF

FY 2022FY 2022

Annual report

PDF

Investor Presentation

Oct 28PDF

FY 2021FY 2021

Annual report

PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

GUJTERC Stock Peers

GUJTERC Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Gujarat Terce Laboratories Ltd	-31.26	4.68	—
Sun Pharmaceutical Industries Ltd	39.50	5.96	0.89%
Torrent Pharmaceuticals Ltd	76.46	19.25	0.74%
Dr Reddy's Laboratories Ltd	19.20	3.20	0.61%

GUJTERC Stock Price Comparison

Compare GUJTERC with any stock or ETF

GUJTERC

GUJTERC Holdings

GUJTERC Shareholdings

GUJTERC Promoter Holdings Trend

GUJTERC Institutional Holdings Trend

GUJTERC Shareholding Pattern

GUJTERC Shareholding History

Foreign Institutions

GUJTERC Insider Trades & Bulk Stock Deals

smallcases containing GUJTERC stock

Looks like this stock is not in any smallcase yet.

GUJTERC Events

GUJTERC Dividend Trend

Dividends

Corp. Actions

Announcements

Legal Orders

GUJTERC Dividend Trend

GUJTERC Dividends

Hmm, looks like data is unavailable here. Please come back after some time

GUJTERC Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Company Update

Announced OnFeb 24, 2026

Gujarat Terce Laboratories Ltd - 524314

Gujarat Terce Laboratories Ltd - 524314 Download

Link

Download

Announced On

Feb 24, 2026

Company Update

Announced OnFeb 5, 2026

Gujarat Terce Laboratories Ltd - 524314

Gujarat Terce Laboratories Ltd - 524314 Download

Link

Download

Announced On

Feb 5, 2026

Company Update

Announced OnFeb 4, 2026

Gujarat Terce Laboratories Ltd - 524314

Gujarat Terce Laboratories Ltd - 524314 Download

Link

Download

Announced On

Feb 4, 2026

Result

Announced OnFeb 4, 2026

Gujarat Terce Laboratories Ltd - 524314

Gujarat Terce Laboratories Ltd - 524314 Download

Link

Download

Announced On

Feb 4, 2026

Board Meeting

Announced OnFeb 4, 2026

Gujarat Terce Laboratories Ltd - 524314

Gujarat Terce Laboratories Ltd - 524314 Download

Link

Download

Announced On

Feb 4, 2026

GUJTERC Legal Orders

Hmm, looks like data is unavailable here. Please come back after some time

GUJTERC Stock News & Opinions

Earnings

Gujarat Terce Laboratories standalone net profit declines 24.75% in the December 2025 quarter

Net profit of Gujarat Terce Laboratories declined 24.75% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 1.01 crore during the previous quarter ended December 2024. Sales declined 3.08% to Rs 12.29 crore in the quarter ended December 2025 as against Rs 12.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales12.2912.68 -3 OPM %9.288.60 - PBDT1.231.08 14 PBT1.130.98 15 NP0.761.01 -25 Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live

2 months agoCapital Market - Live

Earnings

Gujarat Terce Laboratories standalone net profit declines 5.41% in the September 2025 quarter

Net profit of Gujarat Terce Laboratories declined 5.41% to Rs 1.40 crore in the quarter ended September 2025 as against Rs 1.48 crore during the previous quarter ended September 2024. Sales declined 2.78% to Rs 12.93 crore in the quarter ended September 2025 as against Rs 13.30 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales12.9313.30 -3 OPM %14.6212.41 - PBDT1.881.60 18 PBT1.781.51 18 NP1.401.48 -5 Powered by Capital Market - Live

3 months agoCapital Market - Live

Corporate

Gujarat Terce Laboratories to announce Quarterly Result

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 8 November 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live

Earnings

Gujarat Terce Laboratories reports standalone net loss of Rs 0.04 crore in the June 2025 quarter

Net Loss of Gujarat Terce Laboratories reported to Rs 0.04 crore in the quarter ended June 2025 as against net loss of Rs 0.08 crore during the previous quarter ended June 2024. Sales declined 8.75% to Rs 10.85 crore in the quarter ended June 2025 as against Rs 11.89 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales10.8511.89 -9 OPM %-0.090.67 - PBDT0.030.02 50 PBT-0.07-0.07 0 NP-0.04-0.08 50 Powered by Capital Market - Live

6 months agoCapital Market - Live

Corporate

Gujarat Terce Laboratories to discuss results

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting(AGM) of the company will be held on 21 August 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Corporate

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 17 July 2025.Powered by Capital Market - Live

7 months agoCapital Market - Live

Earnings

Gujarat Terce Laboratories reports standalone net loss of Rs 3.39 crore in the March 2025 quarter

Net loss of Gujarat Terce Laboratories reported to Rs 3.39 crore in the quarter ended March 2025 as against net profit of Rs 0.54 crore during the previous quarter ended March 2024. Sales rose 0.90% to Rs 12.32 crore in the quarter ended March 2025 as against Rs 12.21 crore during the previous quarter ended March 2024. For the full year,net loss reported to Rs 0.98 crore in the year ended March 2025 as against net profit of Rs 0.24 crore during the previous year ended March 2024. Sales rose 4.65% to Rs 50.20 crore in the year ended March 2025 as against Rs 47.97 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales12.3212.21 1 50.2047.97 5 OPM %8.528.19 -7.732.65 - PBDT1.070.93 15 3.770.91 314 PBT0.970.84 15 3.390.54 528 NP-3.390.54 PL -0.980.24 PL Powered by Capital Market - Live

9 months agoCapital Market - Live

Corporate

Gujarat Terce Laboratories to discuss results

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 26 May 2025.Powered by Capital Market - Live

9 months agoCapital Market - Live

Frequently asked questions

What is the share price of Gujarat Terce Laboratories Ltd (GUJTERC) today?
The share price of GUJTERC as on 6th March 2026 is ₹38.50. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Gujarat Terce Laboratories Ltd (GUJTERC) share?
The past returns of Gujarat Terce Laboratories Ltd (GUJTERC) share are
- Past 1 week: 0.39%
- Past 1 month: -16.52%
- Past 3 months: -19.61%
- Past 6 months: -3.39%
- Past 1 year: -44.40%
- Past 3 years: 130.82%
- Past 5 years: 383.06%
What are the peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC)?
The peers or stocks similar to Gujarat Terce Laboratories Ltd (GUJTERC) include:
What is the market cap of Gujarat Terce Laboratories Ltd (GUJTERC) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹30.32 Cr as of 6th March 2026.
What is the 52 week high and low of Gujarat Terce Laboratories Ltd (GUJTERC) share?
The 52-week high of Gujarat Terce Laboratories Ltd (GUJTERC) is ₹76.89 and the 52-week low is ₹37.20.
What is the PE and PB ratio of Gujarat Terce Laboratories Ltd (GUJTERC) stock?
The P/E (price-to-earnings) ratio of Gujarat Terce Laboratories Ltd (GUJTERC) is -31.26. The P/B (price-to-book) ratio is 4.68.
Which sector does Gujarat Terce Laboratories Ltd (GUJTERC) belong to?
Gujarat Terce Laboratories Ltd (GUJTERC) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Gujarat Terce Laboratories Ltd (GUJTERC) shares?
You can directly buy Gujarat Terce Laboratories Ltd (GUJTERC) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Gujarat Terce Laboratories Ltd	64.71%	52.18	Pro
Sun Pharmaceutical Industries Ltd	20.15%	72.51
Torrent Pharmaceuticals Ltd	20.79%	68.73
Dr Reddy's Laboratories Ltd	21.06%	61.54

Gujarat Terce Laboratories Ltd

GUJTERC Share Price

GUJTERC Stock Scorecard

GUJTERC Performance & Key Metrics

GUJTERC Performance & Key Metrics

GUJTERC Analyst Ratings & Forecast

Price Upside

Earnings Growth

Rev. Growth

GUJTERC Company Profile

GUJTERC Similar Stocks (Peers)

GUJTERC Similar Stocks (Peers)

GUJTERC Forecast

GUJTERC Forecasts

GUJTERC